New real-world data suggest early lactate clearance can predict massive transfusion needs in upper gastrointestinal bleeding, ...
FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced presentations of data from its IMerge Phase 3 clinical trial ...
More than 80 percent of deaths in the operating room and 50 percent of deaths in the first 24 hours after injury are due to massive blood loss and impaired coagulation. While only 3 percent of ...
The hemoglobin threshold for transfusion of red cells in patients with acute gastrointestinal bleeding is controversial. We compared the efficacy and safety of a restrictive transfusion strategy with ...